Recherche
-
Prenatal therapy with pyrimethamine + sulfadiazine vs spiramycin to reduce placental transmission of toxoplasmosis: a multicenter, randomized trial
(American Journal of Obstetrics and Gynecology. vol. 219, n° 4, pp. 386 e1-386-e9, 2018-10)Article de revue -
A Phase Ia/B Study To Assess The Safety And Immunogenicity Of Placental Malaria Vaccine Candidate: Preliminary Results Of The Primalvac Trial
(American Journal of Tropical Medicine and Hygiene. vol. 99, n° 4, pp. 469-469, 2018)Article de revue -
Adaptive protocols based on predictions from a mechanistic model of the effect of IL7 on CD4 counts
(Statistics in Medicine. vol. 38, n° 2, pp. 221-235, 2019-01-30)Article de revue -
Durable natural killer cell responses after heterologous two-dose Ebola vaccination
(NPJ vaccines. vol. 6, n° 1, pp. 19, 2021-01-29)Article de revueLibre accès -
Correlation between blood telomere length and CD4+ CD8+ T-cell subsets changes 96 weeks after initiation of antiretroviral therapy in HIV-1-positive individuals
(PLoS ONE. vol. 15, n° 4, pp. e0230772, 2020)Article de revueLibre accès -
Cytometree: A binary tree algorithm for automatic gating in cytometry analysis
(Cytometry Part A. vol. 93, n° 11, pp. 1132-1140, 2018-11)Article de revue -
Comment la modélisation peut-elle aider au développement des vaccins ?
(Interstices, 2020-07-08)Article de revue -
High–temporal resolution profiling reveals distinct immune trajectories following the first and second doses of COVID-19 mRNA vaccines
(Science Advances. vol. 8, n° 45, 2022-11-11)Article de revue -
Methodological guidelines to estimate population-based health indicators using linked data and/or machine learning techniques
(Archives of Public Health. vol. 80, n° 1, pp. 9, 2022-01-04)Article de revueLibre accès -
Identification of early gene expression profiles associated with long-lasting antibody responses to the Ebola vaccine Ad26.ZEBOV/MVA-BN-Filo
(Cell Reports. vol. 42, n° 9, pp. 113101, 2023-09-26)Article de revueLibre accès